To determine the potential mechanisms of this phenomenon, we evaluated whether FMT from PC to mice with the K-Ras mutation alters the number of immune cells in blood and pancreatic tissue after pancreatic tumor development. Here, KRAS is linked to pancreatic neoplasm.